These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11399937)
1. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. Avunduk AM; Avunduk MC; Erdöl H; Kapicioglu Z; Akyol N Ophthalmologica; 2001; 215(4):290-3. PubMed ID: 11399937 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children. Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis. Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862 [TBL] [Abstract][Full Text] [Related]
4. Role of ocular cytology in vernal keratoconjunctivitis. Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769 [TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. el-Asrar AM; Tabbara KF; Geboes K; Missotten L; Desmet V Am J Ophthalmol; 1996 Feb; 121(2):156-61. PubMed ID: 8623884 [TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Hingorani M; Calder VL; Buckley RJ; Lightman S Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598 [TBL] [Abstract][Full Text] [Related]
8. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Vichyanond P; Kosrirukvongs P Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179 [TBL] [Abstract][Full Text] [Related]
9. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D; Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775 [TBL] [Abstract][Full Text] [Related]
10. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis. Yücel OE; Ulus ND Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065 [TBL] [Abstract][Full Text] [Related]
12. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial. De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151 [TBL] [Abstract][Full Text] [Related]
13. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial. Keklikci U; Dursun B; Cingu AK Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
15. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Kiliç A; Gürler B Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949 [TBL] [Abstract][Full Text] [Related]
16. Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment. Utine CA; Stern M; Akpek EK Ocul Immunol Inflamm; 2019; 27(7):1184-1193. PubMed ID: 30189151 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis. Wan Q; Tang J; Han Y; Wang D; Ye H Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239 [TBL] [Abstract][Full Text] [Related]
18. Vernal keratoconjunctivitis in Thailand. Kosrirukvongs P; Vichyanond P; Wongsawad W Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748 [TBL] [Abstract][Full Text] [Related]
19. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital. Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377 [TBL] [Abstract][Full Text] [Related]
20. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Vichyanond P; Pacharn P; Pleyer U; Leonardi A Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]